Truist Securities Upgrades ICON Public Limited Company to Buy
Truist Securities has raised its rating on ICON Public Limited Company to Buy with a new price target of $207, a 19.16% upside from the current price.
Key Points
- Truist Securities upgraded ICON Public Limited Company to a Buy on June 30, 2026, setting a price target of $207.
- Truist Securities's $207 price target implies 19.16% upside from ICON Public Limited Company's ($ICLR) current $173.71 share price.
- Shares of ICON Public Limited Company traded at $172.99 on Tuesday, with a market cap of $13.01 billion and a forward P/E ratio of 14.4.
- Peer funds like Artisan Partners and Wellington Management increased their holdings in ICON, with Artisan adding 1.4 million shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Truist Securities has upgraded ICON Public Limited Company (NasdaqGS:ICLR) to a Buy rating as of June 30, 2026. The firm set a new price target of $207, signaling increased confidence in the company's future performance.
Truist Securities vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in ICON Public Limited Company
Several institutional investors have been active in adjusting their stakes in ICON Public Limited Company. Artisan Partners Limited Partnership increased its holdings by 1,404,968 shares, ending with 8,278,945 shares valued at approximately $916.15 million. Wellington Management Group LLP also boosted its position by 1,562,287 shares, resulting in a total of 5,913,037 shares worth about $654.34 million. Harris Associates L.P. made a significant move by adding 1,841,151 shares, bringing its total to 4,351,317 shares valued at $481.52 million. FMR LLC increased its stake by 1,076,111 shares, ending with 4,174,006 shares worth $461.90 million. Invesco Ltd. made a smaller adjustment, adding 121,973 shares to hold 3,878,869 shares valued at $429.24 million.
ICON Public Limited Company Stock Up 2.2%
Shares of ICON Public Limited Company traded near $172.99 on Tuesday. The company has a market capitalization of approximately $13.01 billion and a forward P/E ratio of 14.4, indicating expected future earnings. With a beta of 1.271, the stock shows moderate volatility compared to the overall market. Its 52-week range has seen a low of $66.57 and a high of $211.00, with a 50-day moving average of $128.87 and a 200-day moving average of $149.18. The company's current ratio stands at 1.138, and it has a debt-to-equity ratio of 38.095.
$ICLR price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
In its latest earnings report, ICON Public Limited Company posted revenue of $8.27 billion, reflecting a growth rate of 1.6%. The company achieved a net margin of 2.095% and a return on equity of 1.843%. With earnings per share at $2.28, ICON is set to report its next earnings on July 23, 2026.
Insider Buying and Selling at ICON Public Limited Company
Several insiders have been active in trading shares of ICON Public Limited Company. On May 14, 2026, Dr. John Climax bought and sold 5,005 shares. Similarly, Ronan Martin Murphy and Eugene Pacelli McCague were involved in transactions of 5,005 and 3,255 shares, respectively, on the same day.
Analysts Set New Price Targets
On June 30, 2026, Truist Securities upgraded ICON Public Limited Company to a Buy rating, setting a price target of $207. Mizuho maintained a Buy rating with a target of $190 on June 26, while Citigroup kept a Hold rating with a target of $165 on June 25. BMO Capital continued with a Buy rating and a $187 target. Barclays maintained a Hold rating with a $175 target, and RBC Capital upgraded the stock to Buy with a $185 target on June 25. The consensus among analysts is a Buy, with a mean target price of $175.31 based on 16 opinions.
About ICON Public Limited Company
ICON Public Limited Company is a leading clinical research organization headquartered in Dublin, Ireland. The company provides a wide range of outsourced development and commercialization services to the healthcare sector, including clinical trial management and laboratory services. ICON serves major pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. Founded in 1989, the company employs over 40,350 people globally and is led by CEO Mr. Barry Balfe.
Bottom Line
Truist Securities' upgrade of ICON Public Limited Company to a Buy highlights growing confidence in the company's prospects. Investors and analysts are closely watching ICON's performance as it continues to expand its services in the healthcare sector. Keep in mind that analyst ratings are based on past performance and expectations, and may not reflect current market conditions.
Get ICON Public Limited Company alerts
New 13F filings, insider trades, and analyst moves on $ICLR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.